Braves’ Spencer Schwellenbach and Hurston Waldrep ruled out for the rest of the season with elbow surgery

The Atlanta Braves announced Friday that Spencer Schwellenbach and Hurston Waldrep will undergo season-ending elbow surgery, ending any realistic chance that either starting pitcher would return this year. For a team that has leaned on depth throughout the season, the move is a direct hit to rotation planning and the bullpen workload that follows when starters are removed from the regular rhythm.

The timing is particularly consequential because the Braves were also monitoring Robert Suárez’s right elbow inflammation. According to the club’s update, the organization expects to learn more about Suárez’s potential return when he begins throwing off a mound early next week. That distinction matters: Suárez is being evaluated toward a possible comeback window, while Schwellenbach and Waldrep are headed for surgery with a clear “not this season” outcome.

Schwellenbach and Waldrep had both been part of Atlanta’s starting group, and a season-ending procedure typically means a longer runway of recovery, strengthening and conditioning before baseball activities can restart. While the team did not outline the procedure details in the announcement, it did characterize the surgeries as ending their 2026 season participation.

The Braves’ Friday update also framed how the club is balancing near-term needs with longer-term health decisions. Throwing programs and mound sessions are commonly used to test how an elbow responds to increased stress, and the Braves appear to be using that staged approach with Suárez. At the same time, the organization decided that Schwellenbach and Waldrep’s issues had progressed to a point where surgery was the most definitive path.

From a team-building standpoint, losing two starting arms at once forces Atlanta to make immediate adjustments. Those changes can mean an increased share of innings for the remaining rotation, more bullpen bridging for starters that may be shortened, and greater attention to how often relief pitchers are used before the postseason picture is settled.

For Braves fans, the most direct “what to watch next” is Suárez’s follow-up timeline, beginning with his mound progression early next week. If he can tolerate throwing and show the elbow responds as expected, his status becomes a continuing storyline for late-season bullpen and rotation flexibility, even as Schwellenbach and Waldrep are now out.

Atlanta’s scheduling and roster decisions will be shaped by the gap created by Friday’s surgery announcement. The club will likely lean on its internal depth and game-to-game management in the rotation until it can fully understand how the remaining starters and their spacing will hold up through the stretch.

In the wider MLB landscape, elbow injuries are among the most stubborn to manage because they affect mechanics, recovery time, and pitch effectiveness. With two season-ending surgeries already confirmed, the Braves will be judged less on short-term output and more on how quickly their rotation depth can stabilize after this medical setback.